The UK market has recently experienced some turbulence, with the FTSE 100 and FTSE 250 indices closing lower due to weak trade data from China, impacting companies tied to commodity imports. Amidst ...

Novo Nordisk is also currently awaiting a decision from the FDA, having previously applied for approval of its Wegovy weight-loss pill. As part of the U.S. pricing deal with the administration earlier ...

A once-weekly 7.2 mg dose of the drug, known as semaglutide but marketed as Wegovy for weight-loss, has shown to help patients lose an average of 20.7% of their body weight in late-stage trials ...